KODIAK SCIENCES INC. Noncash or Part Noncash Acquisition, Fixed Assets Acquired
KODIAK SCIENCES INC. (KOD) reported Noncash or Part Noncash Acquisition, Fixed Assets Acquired of $855.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 · last filed 2026-08-13
- KODIAK SCIENCES INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2026-06-30 was $557.00K.
- KODIAK SCIENCES INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2026-03-31 was $298.00K, a 313.89% increase year-over-year.
- KODIAK SCIENCES INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-12-31 was $866.00K, a 2305.56% increase year-over-year.
- KODIAK SCIENCES INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-09-30 was -$1.00K.
- KODIAK SCIENCES INC. noncash or part noncash acquisition, fixed assets acquired for fiscal 2025 was $878.00K, a 1656.00% increase from fiscal 2024.
- KODIAK SCIENCES INC. noncash or part noncash acquisition, fixed assets acquired for fiscal 2024 was $50.00K.
- KODIAK SCIENCES INC. noncash or part noncash acquisition, fixed assets acquired for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- KODIAK SCIENCES INC. noncash or part noncash acquisition, fixed assets acquired for fiscal 2022 was $2.92M, a 86.17% decline from fiscal 2021.
| Period end | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 6 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 9 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 12 month |
|---|---|---|---|---|
| 2026-06-30 | $557.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $855.00K 10-Q · filed 2026-08-13 | $1.72M derived: sum of 3 quarters · filed 2026-08-13 | $1.72M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $298.00K 10-Q · filed 2026-05-07 | $1.16M derived: sum of 2 quarters · filed 2026-05-07 | $1.16M derived: sum of 3 quarters · filed 2026-05-07 | $1.10M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $866.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $865.00K derived: sum of 2 quarters · filed 2026-03-31 | $806.00K derived: sum of 3 quarters · filed 2026-08-13 | $878.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$60.00K derived: sum of 2 quarters · filed 2026-08-13 | $12.00K 10-Q · filed 2025-11-13 | $48.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$59.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $13.00K 10-Q · filed 2026-08-13 | $49.00K derived: sum of 3 quarters · filed 2026-08-13 | -$117.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $72.00K 10-Q · filed 2026-05-07 | $108.00K derived: sum of 2 quarters · filed 2026-05-07 | -$58.00K derived: sum of 3 quarters · filed 2026-05-07 | $122.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$130.00K derived: sum of 2 quarters · filed 2026-03-31 | $50.00K derived: sum of 3 quarters · filed 2026-03-31 | $50.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | -$166.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $14.00K derived: sum of 2 quarters · filed 2025-11-13 | $14.00K 10-Q · filed 2025-11-13 | -$27.45M derived: sum of 4 quarters · filed 2026-03-31 |
| 2024-06-30 | $180.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $180.00K 10-Q · filed 2025-08-13 | -$27.29M derived: sum of 3 quarters · filed 2026-03-31 | -$27.48M derived: sum of 4 quarters · filed 2026-03-31 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-14 | -$27.46M derived: sum of 2 quarters · filed 2026-03-31 | -$27.66M derived: sum of 3 quarters · filed 2026-03-31 | -$28.80M derived: sum of 4 quarters · filed 2026-03-31 |
| 2023-12-31 | -$27.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$27.66M derived: sum of 2 quarters · filed 2026-03-31 | -$28.80M derived: sum of 3 quarters · filed 2026-03-31 | $0.00 10-K · filed 2026-03-31 |
| 2023-09-30 | -$197.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$1.33M derived: sum of 2 quarters · filed 2024-11-14 | $27.46M 10-Q · filed 2024-11-14 | $26.06M derived: sum of 4 quarters · filed 2025-03-27 |
| 2023-06-30 | -$1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $27.66M 10-Q · filed 2024-08-14 | $26.26M derived: sum of 3 quarters · filed 2025-03-27 | $20.86M derived: sum of 4 quarters · filed 2025-03-27 |
| 2023-03-31 | $28.80M 10-Q · filed 2024-05-15 | $27.39M derived: sum of 2 quarters · filed 2025-03-27 | $21.99M derived: sum of 3 quarters · filed 2025-03-27 | $20.22M derived: sum of 4 quarters · filed 2025-03-27 |
| 2022-12-31 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$6.80M derived: sum of 2 quarters · filed 2025-03-27 | -$8.57M derived: sum of 3 quarters · filed 2025-03-27 | $2.92M 10-K · filed 2025-03-27 |
| 2022-09-30 | -$5.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$7.17M derived: sum of 2 quarters · filed 2023-11-14 | $4.32M 10-Q · filed 2023-11-14 | $14.68M derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-06-30 | -$1.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $9.72M 10-Q · filed 2023-08-14 | $20.08M derived: sum of 3 quarters · filed 2024-03-28 | $28.98M derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-03-31 | $11.49M 10-Q · filed 2023-05-15 | $21.85M derived: sum of 2 quarters · filed 2024-03-28 | $30.75M derived: sum of 3 quarters · filed 2024-03-28 | $30.61M derived: sum of 4 quarters · filed 2024-03-28 |
| 2021-12-31 | $10.36M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $19.27M derived: sum of 2 quarters · filed 2024-03-28 | $19.12M derived: sum of 3 quarters · filed 2024-03-28 | $21.09M 10-K · filed 2024-03-28 |
| 2021-09-30 | $8.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $8.76M derived: sum of 2 quarters · filed 2022-11-09 | $10.73M 10-Q · filed 2022-11-09 | $10.50M derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-06-30 | -$145.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.82M 10-Q · filed 2022-08-09 | $1.59M derived: sum of 3 quarters · filed 2023-03-28 | $2.55M derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-03-31 | $1.97M 10-Q · filed 2022-05-10 | $1.74M derived: sum of 2 quarters · filed 2023-03-28 | $2.69M derived: sum of 3 quarters · filed 2023-03-28 | $2.77M derived: sum of 4 quarters · filed 2023-03-28 |
| 2020-12-31 | -$231.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $726.00K derived: sum of 2 quarters · filed 2023-03-28 | $803.00K derived: sum of 3 quarters · filed 2023-03-28 | $803.00K 10-K · filed 2023-03-28 |
| 2020-09-30 | $957.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $1.03M derived: sum of 2 quarters · filed 2021-11-09 | $1.03M 10-Q · filed 2021-11-09 | $897.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $77.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $77.00K 10-Q · filed 2021-08-09 | -$60.00K derived: sum of 3 quarters · filed 2021-08-09 | -$60.00K derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-10 | -$137.00K derived: sum of 2 quarters · filed 2021-05-10 | -$137.00K derived: sum of 3 quarters · filed 2021-05-10 | -$110.00K derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | -$137.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$137.00K derived: sum of 2 quarters · filed 2021-03-01 | -$110.00K derived: sum of 3 quarters · filed 2021-03-01 | $0.00 10-K · filed 2021-03-01 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $27.00K derived: sum of 2 quarters · filed 2020-11-09 | $137.00K 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $137.00K 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $110.00K 10-Q · filed 2020-05-11 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-01 | |||
| 2017-12-31 | $0.00 10-K · filed 2019-03-27 | |||
| 2016-12-31 | $731.00K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |